JAK inhibitor PRT 062070, Purity ≥98%

Synonym: Cerdulatinib; 1198300-79-6; Cerdulatinib (PRT062070); Cerdulatinib [INN]; PRT062070; UNII-D1LXQ45S1O; D1LXQ45S1O; JAK inhibitor

CAS Number: 1198300-79-6
Compound CID: 44595079

Product Size

10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

PRT 062070 is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets AMPK, ARK5, CHK1, Flt3, Flt4, FMS, GCK, Itk, JAK1, JAK2, and JAK3.

Molecular Weight

445.54

Molecular Formula

C₂₀H₂₇N₇O₃S

Targets

AMPK: 6 nM; ARK5: 4 nM; CHK1: 42 nM; Flt3: 90 nM; Flt4: 51 nM; FMS: 5 nM; GCK: 18 nM; Itk: 194 nM; JAK1: 12 nM; JAK2: 6 nM; JAK3: 8 nM

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

PRT 062070 can be utilized to investigate the inhibition of JAK3 and other kinases.

Storage

Store at -20ºC.